Literature DB >> 15940057

Partial splenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin.

Rafael Bárcena, Luis Gil-Grande, Javier Moreno, José R Foruny, Elena Otón, Miguel García, Javier Blázquez, Juan Sánchez, Ana Moreno, Alberto Moreno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15940057     DOI： 10.1097/01.tp.0000155424.52939.3d

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  5 in total

1.  Effect of liver transplantation on spleen size, collateral veins, and platelet counts.

Authors:  Fumio Chikamori; Seigo Nishida; Gennaro Selvaggi; Panagiotis Tryphonopoulos; Jang I Moon; David M Levi; Tomoaki Kato; Eddie R Island; Akira Maki; Akin Tekin; Andreas G Tzakis
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

2.  Embolization of nonliver visceral tumors.

Authors:  Paul G Thacker; Jeremy L Friese; Matthew Loe; Peter Biegler; Michael Larson; James Andrews
Journal:  Semin Intervent Radiol       Date:  2009-09       Impact factor: 1.513

Review 3.  Treatment modalities for hypersplenism in liver transplant recipients with recurrent hepatitis C.

Authors:  Lena Sibulesky; Justin-H Nguyen; Ricardo Paz-Fumagalli; C-Burcin Taner; Rolland-C Dickson
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

Review 4.  Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection.

Authors:  Sumit Dahal; Smrity Upadhyay; Rashmi Banjade; Prajwal Dhakal; Nabin Khanal; Vijaya Raj Bhatt
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-03-01       Impact factor: 2.576

5.  Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia.

Authors:  Tamer A Elbedewy; Mohamed A Elsebaey; Samah A Elshweikh; Heba Elashry; Sherief Abd-Elsalam
Journal:  Ther Clin Risk Manag       Date:  2019-02-11       Impact factor: 2.423
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.